Clinical affairs: Ongoing initiatives

Ongoing recommendations for management

Points to Consider for Conducting Clinical Trials in Individuals at risk of Rheumatoid Arthritis
Conveor: Paul Emery

Development And Validation of a EULAR disease activity score in adult onset Still’s Disease:  the “DAVID” project
Convenor: Roberto Giacomelli

Therapeutic Drug Monitoring of Biopharmaceuticals in Rheumatology
Convenor: John Isaacs

EULAR Recommendations for cardiovascular risk management in Rheumatic and Musculoskeletal Diseases (including SLE and the antiphospholipid syndrome)
Convenor: Michael Nurmohamed/Maria Tektonidou

2019 Update of the EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies
Convenor: Josef Smolen/Laure Gossec

2019 Update of the EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease modifying antirheumatic drugs
Convenor: Josef Smolen

EULAR Recommendations /Points to Consider for the intra-articular treatment of arthropathies (including synoviorthesis)
Convenor: Jaqueline Uson

Update of the EULAR recommendations for the diagnosis and the management of rheumatic immune-related adverse events due to cancer immunotherapy
Convenor: Thierry Schaeverbeke

Update of the EULAR recommendations for the management of difficult to treat rheumatoid arthritis
Convenor: György Nagy


Update of the EULAR recommendations for the management of lupus nephritis
Convenor: Dimitrios Boumpas

Points to consider for the development, evaluation and implementation of mobile health applications for self-management in patients with rheumatic diseases
Convenors: Aurélie Najm, Francis Berenbaum

Development of EULAR points to consider/recommendations for including the perspective of young patients with inflammatory arthritis into patient-reported outcomes measures
Convenor: Paul Studenic

Development of evidence-based and consensus-based EULAR Recommendations on the therapeutic management of Sjögren's Syndrome
Convenor: Manuel Casals

Related information

EULAR/ACR collaborative projects

For initiatives with international relevance, the relevant standing committee from EULAR seeks collaboration with the quality-of-care committee of the American College of Rheumatology (ACR). This cooperation includes the development and validation of criteria sets for the development of recommendations regarding conducting clinical trials.

EULAR and ACR strive for a transparent and collaborative relationship in order to avoid overlaps and to identify and promote synergies.

Read more